A phase I clinical trial to study the safety of treatment with tipifarnib combined with bortezomib in patients with advanced stages of myelodysplastic syndrome and oligoblastic acute myeloid leukemia

2021/03/31 by Petra Muus, Saskia Langemeijer, Sandra van Bijnen +4
Medicine · #Acute Myeloid Leukemia Research #Chronic Myeloid Leukemia Treatments #Myeloproliferative Neoplasms: Diagnosis and Treatment

paper · doi:10.1016/j.leukres.2021.106573

openalex publication_date 2021/03/31 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Citations

• Four different regimens of farnesyltransferase inhibitor tipifarnib in older, untreated acute myeloid leukemia patients: North American Intergroup Phase II study SWOG S0432